Results 91 to 100 of about 42,868 (258)

Phase II clinical trial of robotic stereotactic body radiosurgery for metastatic gynecologic malignancies

Frontiers in Oncology, 2012
Background Recurrent gynecologic cancers are often difficult to manage without significant morbidity. We conducted a phase II study to assess the safety and the efficacy of ablative robotic stereotactic body radiosurgery (SBRT) in women with metastatic ...
Charles eKunos, James eBrindle, Steven eWaggoner, Kristine eZanotti, Kimberly eResnick, Nancy eFusco, Ramon eAdams, Robert eDebernardo   +7 more
doaj   +1 more source

Performance Comparison of Knowledge-Based Dose Prediction Techniques Based on Limited Patient Data. [PDF]

, 2018
PurposeThe accuracy of dose prediction is essential for knowledge-based planning and automated planning techniques. We compare the dose prediction accuracy of 3 prediction methods including statistical voxel dose learning, spectral regression, and ...
Landers, Angelia, Neph, Ryan, Ruan, Dan, Scalzo, Fabien, Sheng, Ke   +4 more
core  

Biochemical Safety of SBRT to Multiple Intrahepatic Lesions for Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma
Jacob T Hall,1 Andrew M Moon,2,3 Michael Young,1 Xianming Tan,3,4 Rami Darawsheh,5 Flora Danquah,3 Joel E Tepper,1,3 Ted K Yanagihara1,3 1Department of Radiation Oncology, University of North Carolina Hospitals, Chapel Hill, NC, USA; 2Division of ...
Hall JT, Moon AM, Young M, Tan X, Darawsheh R, Danquah F, Tepper JE, Yanagihara TK   +7 more
doaj  

Research study on materials processing in space, experiment M512 [PDF]

Gallium arsenide, a commercially valuable semiconductor, has been prepared from the melt (M.P. 1237C), by vapor growth, and by growth from metallic solutions.
Hopkins, R. H., Kim, H. B., Rubenstein, M.   +2 more
core   +1 more source

Exploratory analysis using machine learning to predict for chest wall pain in patients with stage I non-small-cell lung cancer treated with stereotactic body radiation therapy. [PDF]

, 2018
Background and purposeChest wall toxicity is observed after stereotactic body radiation therapy (SBRT) for peripherally located lung tumors. We utilize machine learning algorithms to identify toxicity predictors to develop dose-volume constraints ...
Berman, Abigail T, Chao, Hann-Hsiang, Heskel, Marina, Luna, Jose M, Simone, Charles B, Solberg, Timothy D, Valdes, Gilmer   +6 more
core   +1 more source

Evaluation of 3D vs 4D Cone-beam CT (CBCT) Target Localization Methods for Free Breathing Liver Stereotactic Body Radiotherapy (SBRT) [PDF]

, 2016
Winnie Li, Katherine Kratz, Alana Pellizzari, Janet Hsu, Nathan Becker, T. Stanescu, John Kim, D Moseley   +7 more
openalex   +1 more source

Efficacy and safety of stereotactic body radiotherapy for hepatocellular carcinoma with tumor thrombus in right atrium: a two-center retrospective review

Radiation Oncology
Background We sought to evaluate the efficacy and toxicity of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma with tumor thrombus in right atrium (RATT). Methods HCC patients with RATT treated with SBRT at two institutions between June
Yongjie Shui, Jia Yang, Xianzhi Zhao, Yang Yang, Chunshan Yu, Dongjun Dai, Liang Chen, Haiyan Chen, Di Chen, Xia Li, Lihong Liu, Qiaoying Tian, Yinglu Guo, Huojun Zhang, Qichun Wei   +14 more
doaj   +1 more source

MVCT Based Evaluation Of The Intrafractional Target Displacement During SBRT In Lungs For Patients Immobilized Using A Commercial System [PDF]

, 2011
S Kriminski, D Pavord, Maureen O’Connor, Ah-Hyeon Kim, E. Farhangi   +4 more
openalex   +1 more source

Stereotactic body radiation therapy is beneficial for a subgroup of patients with urothelial cancer and solitary metastatic disease: a single institution real-world experience

Radiation Oncology
Background Standard treatment options for patients with metastatic urothelial cancer (mUC) include systemic platinum-based chemotherapy, immunotherapy, antibody-drug-conjugates, and targeted therapy.
Fernanda Costa Svedman, Karin Holmsten, Faith Jawdat, Wehazit Hailom, Daniel Alm, Vitali Grozman, Anders Ullén   +6 more
doaj   +1 more source

A brief review of low-dose rate (LDR) and high-dose rate (HDR) brachytherapy boost for high-risk prostate [PDF]

, 2019
For patients with unfavorable or high-risk prostate cancer, dose escalated radiation therapy leads to improved progression free survival but attempts to deliver increased dose by external beam radiation therapy (EBRT) alone can be limited by late ...
Baumann, Brian C, Fischer-Valuck, Benjamin W, Gay, Hiram A, Michalski, Jeff M, Patel, Sagar   +4 more
core   +1 more source